Archived Medical News Stories

RSSArchived Drug Trial News Stories - March 2009

Date Title Comments Rating
2009-03-31 ImQuest presents data on the anti-hepatitis B virus activity of Pyrimidinediones 0 None
2009-03-31 New smoking cessation drug varenicline tartrate shows promise in trials 0 None
2009-03-30 SARcode announces results of phase 1 trial of SAR 1118 ophthalmic solution in healthy adult subjects 0 None
2009-03-30 Corthera's Relaxin in acute heart failure shows promising results 0 None
2009-03-30 Nile Therapeutics update on phase II CD-NP trial for acute heart failure 0 None
2009-03-29 New Lantheus study finds significant survival benefit for critically ill patients undergoing contrast-enhanced echocardiography 0 None
2009-03-29 NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management 0 None
2009-03-29 Medgenics’ phase I/II clinical trial shows EPODURE continuous anemia treatment lasting 5 months in kidney disease patients 0 None
2009-03-29 Eli Lilly announces inconclusive study results for mGlu2/3 in acute schizophrenia 0 None
2009-03-29 ARCA biopharma presents data from phase 3 BEST trial of Gencaro 0 None
2009-03-29 Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes 0 None
2009-03-29 CRESTOR found to reduced CV risk in patients achieving low LDL-C and hsCRP targets in new Jupiter analysis 0 None
2009-03-29 CRESTOR (rosuvastatin) shown to significantly reduce risk of venous thromboembolism 0 None
2009-03-29 A comparative analysis of four beta blocker trials 0 None
2009-03-29 ArunA Biomedical to commercialize human embryonic stem cell derived mesenchymal cells 0 None
2009-03-29 Amicus Therapeutics presents positive results from phase 2 extension study of Amigal for Fabry disease 0 None
2009-03-29 RegeneRx reports phase II venous stasis trial results 0 None
2009-03-29 Positive phase 3 uveitis trial results for voclosporin 0 None
2009-03-29 Add-on treatment may reduce treatment-associated weight gain caused by antipsychotic treatments 0 None
2009-03-26 Oxycodone effective against shingles pain 0 None
2009-03-24 Rexahn Pharmaceuticals starts phase II pancreatic cancer trial 0 None
2009-03-24 Radius starts Ppase 2a trial of RAD1901 in menopausal hot flashes 0 None
2009-03-24 Orexo reports on efficacy study in allergic rhinitis with OX914 0 None
2009-03-24 Gilead commences phase II trial of Cicletanine for pulmonary arterial hypertension 0 None
2009-03-24 Canadian researchers to launch clinical trial to determine efficacy of treating latent TB with four-month course of Rifampin 0 None
2009-03-24 Phase II clinical trial of tuberculosis vaccine candidate to begin next month in South Africa 0 None
2009-03-23 Review of probiotics in the treatment of Irritable Bowel Syndrome 0 None
2009-03-23 NEJM Letters respond to recent studies on malaria vaccines, treatments 0 None
2009-03-22 Cathepsin B increases apoptosis in fulminant hepatic failure 0 None
2009-03-20 SemBioSys Genetics announces clinical results with plant-produced insulin 0 None
2009-03-20 Potential colon cancer being tested 0 None
2009-03-17 Drug pactimibe does not appear to reduce progression of atherosclerosis 0 None
2009-03-17 Cephalon announces positive results from study of NUVIGIL in bipolar depression 0 None
2009-03-17 Alba Therapeutics announces next clinical trial of lead compound, Larazotide Acetate 0 None
2009-03-16 Budesonide nasal wash shows promise for chronic rhinosinusitis 0 3.8
2009-03-16 Trial of new combination treatment targeting hormone receptor-positive locally advanced breast cancer 0 None
2009-03-16 Helix BioPharma receives approval to start phase II study of topical interferon alpha-2b in low-grade cervical lesions 0 None
2009-03-16 Healthpoint intiates phase II clinical trial to evaluate effectiveness of HP802-247 in venous leg ulcers 0 None
2009-03-15 Nobilon's intranasal influenza vaccine begins phase I clinical development 0 None
2009-03-12 Schering-Plough's investigational oral thrombin receptor antagonist meets primary endpoint in a newly published study 0 None
2009-03-12 Biothera receives approval to launch two lung cancer trials 0 None
2009-03-12 BioCis Pharma starts trial of novel topical drug for dermatology 0 None
2009-03-11 Rituximab may be effective in treating membranous nephropathy 0 None
2009-03-11 Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint 0 5
2009-03-11 Rituximab useful for advanced indolent lymphoma 0 None
2009-03-10 Long-term effects of two common drugs for early Parkinson's similar 0 None
2009-03-05 Vaginal microbicide gel shows promise as HIV prevention method for women 0 None
2009-03-04 Rituximab reduces kidney inflammation in patients with severe lupus nephritis 0 None
2009-03-03 Pharmaxis announces NDA filing for Aridol 0 None
2009-03-03 Trial looks at telmisartan in treating non-alcoholic steatohepatitis 0 None
2009-03-03 Bionovo announces publication of positive trial results for Menerba 0 None
2009-03-03 Aerovance starts trial of Aerovant for uncontrolled asthma 0 None
2009-03-03 Type 1 diabetes patients sought for UT Southwestern clinical drug trial 0 None
2009-03-02 Angiogenesis inhibitors, study points to limitations, solutions 0 None
2009-03-02 Biphasic insulin provides significant improvements in more than 52,000 diabetic patients 0 None
2009-03-02 Chantix side effects no worse for people with history of depression 0 2
2009-03-01 Experimental drug fampridine improves mobility for some MS patients 1 5


57 posts
16 raters